Secondly, due to the prognostic value of HERC3 and the existence of the former mentioned gradient differential expression trend, perhaps HERC3 can be used as an early diagnosis indicator for CRC and also a prognostic biomarker for CRC diagnosis and treatment. The gene discussed is HERC3; the disease is colorectal carcinoma.